Holen Sie sich die Stockscreener-App
4.32
1.41%
0.06
Schlusskurs vom Vortag:
$4.26
Offen:
$4.3
24-Stunden-Volumen:
103.43K
Relative Volume:
0.59
Marktkapitalisierung:
$80.08M
Einnahmen:
$117.59M
Nettoeinkommen (Verlust:
$-74.85M
KGV:
-1.0347
EPS:
-4.175
Netto-Cashflow:
$-34.25M
1W Leistung:
+19.01%
1M Leistung:
-4.42%
6M Leistung:
+0.70%
1J Leistung:
-76.61%
1-Tages-Spanne:
$4.11
$4.4499
1-Wochen-Bereich:
$3.574
$4.4499
52-Wochen-Spanne:
$3.00
$21.98
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
4.32 | 78.97M | 117.59M | -74.85M | -34.25M | -4.175 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN
Outset Medical: General counsel Brottem sells $9,760 in shares - Investing.com India
Outset Medical CEO Leslie Trigg sells $12,746 in OM shares - Investing.com India
Outset Medical EVP Marc Nash sells $5,853 in common stock - Investing.com India
Outset Medical: General counsel Brottem sells $9,760 in shares By Investing.com - Investing.com South Africa
Outset Medical CEO Leslie Trigg sells $12,746 in OM shares By Investing.com - Investing.com Nigeria
Outset Medical EVP Marc Nash sells $5,853 in common stock By Investing.com - Investing.com Nigeria
Outset Medical (OM) EVP sells 1,582 shares in tax-related ‘sell to cover’ - Stock Titan
BML Investment Partners takes 13.6% stake in Outset Medical (OM) - Stock Titan
Outset Medical (OM) major holder assigned 323K shares via June 2026 puts - Stock Titan
Outset Medical (OM) price target decreased by 14.81% to 7.82 - MSN
OM (NASDAQ: OM) settles 4,277 RSUs; Marc Nash sold 1,830 shares earlier - Stock Titan
OM (NASDAQ: OM) files Form 144 for 9,319 RSU settlement on 05/15/2026 - Stock Titan
OM (NASDAQ) director files Form 144 reporting 5,033 RSUs settled and prior sale - Stock Titan
Outset Medical (OM) amendment shows no beneficial ownership by Alyeska entities - Stock Titan
Woodline Partners holds 292,437 OM shares (1.6%) (OM) - Stock Titan
BTIG Maintains Outset Medical (OM) Buy Recommendation - MSN
Outset Medical (OM) Q1 2026 Earnings Transcript - AOL.com
Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff - Insider Monkey
BML Investment Partners files 13G/A reporting 11.8% stake in Outset Medical (OM) - Stock Titan
Outset Medical (OM) 10% holder entities exercise derivatives to acquire over 294K shares - Stock Titan
Outset Medical to Present at RBC Global Healthcare Conference - The Manila Times
Dialysis tech firm Outset Medical to speak at RBC health conference - Stock Titan
Outset Medical net revenue drops 6% to USD 27.9M in Q1 2026 - Medical Buyer
Outset Medical, Inc. (OM) reports Q1 loss, lags revenue estimates - MSN
Outset Medical (OM) Q4 2025 Earnings Transcript - The Globe and Mail
Outset Medical (OM) Receives a Hold from RBC Capital - The Globe and Mail
Outset Medical Bets on Margin Gains and Next-Gen Tableau - TipRanks
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Outset Medical, Inc. Q1 2026 SEC 10-Q Report – Financial Statements, Management Discussion, and Key Risks - Minichart
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Q1 2026 Outset Medical Inc Earnings Call Transcript - GuruFocus
Outset Medical Q1 Earnings Call Highlights - Yahoo Finance
Outset Medical, Inc. (NASDAQ:OM) Q1 2026 Earnings Call Transcript - insidermonkey.com
Earnings call transcript: Outset Medical’s Q1 2026 results show optimism with strategic focus - Investing.com
Earnings call transcript: Outset Medical’s Q1 2026 results show optimism with strategic focus By Investing.com - Investing.com South Africa
Outset Medical : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Outset Medical Inc. (OM) Misses Q1 EPS by 83c - StreetInsider
Outset Medical, Inc. 1Q 2026: Revenue $27.86M, EPS $(1.03) — 10-Q Summary - TradingView
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
[10-Q] Outset Medical, Inc. Quarterly Earnings Report - Stock Titan
Outset Medical (NASDAQ:OM) Falls After Q1 Revenue Miss, Despite Record Gross Margins - ChartMill
Outset Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Outset Medical (OM) Q1 2026 revenue dips 6% but margins and loss improve - Stock Titan
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Outset Medical Inc-Aktie (OM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nash Marc | EVP Operations R&D & Service |
May 15 '26 |
Sale |
3.70 |
1,582 |
5,853 |
38,393 |
| Brottem John L. | General Counsel |
May 15 '26 |
Sale |
3.70 |
2,638 |
9,761 |
30,277 |
0.22%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):